Cancer Stage Shifting Initiative
The mission of the Cancer Stage Shifting Initiative is to move us from late stage to early- stage diagnosis and treatment of cancer, improving cancer care and reducing cancer deaths for all, with a particular focus on equity and underrepresented populations.
Stage shifting will require system changes brought on by a coordinated effort that involves advocacy, education, communications and outreach, upgrading of clinical trial processes, and associated demonstration studies to develop evidence focused on the screening, detection, diagnosis and treatment of cancer in minority populations. These components work together to operate as a learning community where the bench and bedside are integrated into a stage-shifting maneuver to eliminate inequities.
Take a look at our 2023 Endpoints Report for insights on Phase 1 of the CSSI Action Plan, which launched in the fourth quarter of 2022.